Trial intelligence / Profile preview

Rescue therapy of tunnel/pocket infections of central venous catheters with continuous antibiotic infusion

2006-002146-10Phase 2Completed

Sponsor
Istituto Giannina Gaslini
Start
Aug 2006
Modality
Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of vancomycin, linezolid, ceftazidime and meropenem in central venous catheter tunnel infection (CVCTI) and central venous catheter-associated pocket infection (CVC-PI), sponsored by Istituto Giannina Gaslini. Primary endpoint: Efficacy of rescue treatment. Started Aug 2006; status: completed.

02

Drugs

vancomycinlinezolidceftazidimemeropenem
03

Conditions

central venous catheter tunnel infection (CVCTI)central venous catheter-associated pocket infection (CVC-PI)

Beyond the preview

Go deeper on 2006-002146-10.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-002146-10.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call